Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Clinical trial NCT04810910 · UNKNOWN
Trial details
- NCT number
- NCT04810910
- Sponsor
- Zhejiang Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-30
- Primary completion
- 2025-03-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.